封面
市场调查报告书
商品编码
1313387

神经血管设备市场:按类型、用途- 2023-2030 年全球预测

Neurovascular Neurology Devices Market by Type, Application - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2023 年,全球神经血管设备市场将达到 30.0527 亿美元,年复合成长率7.77%,预计到 2030 年将出现惊人增长,达到 50.8234 亿美元。

FPNV定位矩阵

FPNV定位矩阵对于评估全球神经血管器械市场至关重要。透过检查业务策略和产品满意度的关键指标,我们对供应商进行全面评估,使您能够根据您的特定需求做出明智的资讯。这种进阶分析将供应商分为四个像限,并取得了不同程度的成功:前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市占率分析

市场占有率分析可以深入了解供应商在特定市场领域的当前地位。比较供应商对总收入、基本客群和其他关键指标的贡献,可以帮助公司更好地了解他们在争夺市场份额时的表现以及面临的情况。该分析还揭示了特定行业的竞争程度、累积和合併的优势以及研究基准年的合併特征。

本报告提供了以下几点见解:

1. 市场渗透率:提供有关主要企业所服务的市场的全面资讯。

2. 市场开发:提供有关利润丰厚的新兴市场的详细资讯,并分析其在成熟市场的渗透率。

3. 市场多元化:提供有关新产品发布、未开发领域、最新发展和投资的详细资讯。

4.市场趋势:全面了解COVID-19、俄罗斯-乌克兰衝突和高通膨的累积影响。

5.竞争评估与资讯:对主要企业的市场占有率、策略、产品、认证、法规状况、专利状况、製造能力等进行综合评估。

6. 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。

本报告回答了以下问题:

1.神经血管器械全球市场规模及预测是多少?

2.在预测期内,COVID-19 对全球神经血管器械市场的阻碍因素和影响有哪些?

3. 在预测期内,全球神经血管设备市场需要投资哪些产品/细分市场/用途/领域?

4.你们在全球神经血管器材市场的竞争策略是什么?

5. 全球神经血管器械市场的技术趋势和法律规范是什么?

6.全球神经血管器械市场主要厂商的市占率是多少?

7. 哪些型态和策略性措施被认为适合进入全球神经血管器械市场?

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

  • 市场动态
    • 促进因素
      • 神经病变的发生率增加
      • 高血压、饮酒和吸烟增加
      • 微创手术需求不断成长
    • 抑制因素
      • 缺乏熟练的神经外科医生
    • 机会
      • 神经血管设备相关技术进步快速成长
      • 采用先进的血栓清除技术
    • 任务
      • 神经血管手术的手术费用高
  • 市场趋势
  • COVID-19 的累积影响
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范
  • 客户客製化

第6章神经血管设备市场:依类型

  • 介绍
  • 颈动脉支架系统
  • 脑动脉瘤及AVM血管内栓塞系统
  • 脑血栓清除器
  • 动脉瘤分流器
  • 颅内支架系统

第7章神经血管设备市场:依用途

  • 介绍
  • 脑动脉瘤
  • 脑动脉狭窄
  • 中风

第8章美洲神经血管设备市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第9章亚太神经血管器材市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第10章欧洲、中东和非洲神经血管器材市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第11章竞争形势

  • FPNV定位矩阵
  • 市占率分析:主要企业
  • 竞争情境分析:主要企业

第12章上市公司名单

第13章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-036C5CF3B4E5

The Global Neurovascular Neurology Devices Market is forecasted to grow significantly, with a projected USD 3,005.27 million in 2023 at a CAGR of 7.77% and expected to reach a staggering USD 5,082.34 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Neurovascular Neurology Devices Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Neurovascular Neurology Devices Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Type, market is studied across Carotid Artery Stenting System, Cerebral Aneurysm & AVM Endovascular Embolization Systems, Cerebral Thrombectomy Devices, Flow Diverter for Aneurysm, and Intracranial Stent Systems. The Cerebral Thrombectomy Devices is projected to witness significant market share during forecast period.

Based on Application, market is studied across Cerebral Aneurysm, Cerebral Artery Stenosis, and Stroke. The Cerebral Aneurysm is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Neurovascular Neurology Devices Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Neurovascular Neurology Devices Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Neurovascular Neurology Devices Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Neurovascular Neurology Devices Market?

4. What is the competitive strategic window for opportunities in the Global Neurovascular Neurology Devices Market?

5. What are the technology trends and regulatory frameworks in the Global Neurovascular Neurology Devices Market?

6. What is the market share of the leading vendors in the Global Neurovascular Neurology Devices Market?

7. What modes and strategic moves are considered suitable for entering the Global Neurovascular Neurology Devices Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Neurovascular Neurology Devices Market, by Type, 2022 vs 2030
  • 4.3. Neurovascular Neurology Devices Market, by Application, 2022 vs 2030
  • 4.4. Neurovascular Neurology Devices Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increase in the incidence of neurological disorders
      • 5.1.1.2. Increasing prevalence of hypertension, alcohol consumption, and smoking
      • 5.1.1.3. Rising demand for minimally invasive surgical procedures
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of skilled neurosurgeons
    • 5.1.3. Opportunities
      • 5.1.3.1. Surge in technological advancements related to neurovascular devices
      • 5.1.3.2. Adoption of advances in thrombectomy technologies
    • 5.1.4. Challenges
      • 5.1.4.1. High procedural cost of neurovascular surgeries
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Neurovascular Neurology Devices Market, by Type

  • 6.1. Introduction
  • 6.2. Carotid Artery Stenting System
  • 6.3. Cerebral Aneurysm & AVM Endovascular Embolization Systems
  • 6.4. Cerebral Thrombectomy Devices
  • 6.5. Flow Diverter for Aneurysm
  • 6.6. Intracranial Stent Systems

7. Neurovascular Neurology Devices Market, by Application

  • 7.1. Introduction
  • 7.2. Cerebral Aneurysm
  • 7.3. Cerebral Artery Stenosis
  • 7.4. Stroke

8. Americas Neurovascular Neurology Devices Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Neurovascular Neurology Devices Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Neurovascular Neurology Devices Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. List of Company Mentioned

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. NEUROVASCULAR NEUROLOGY DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, 2022 VS 2030
  • FIGURE 3. NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
  • FIGURE 5. NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 6. NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 7. NEUROVASCULAR NEUROLOGY DEVICES MARKET DYNAMICS
  • FIGURE 8. NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. UNITED STATES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. ASIA-PACIFIC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. NEUROVASCULAR NEUROLOGY DEVICES MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 15. NEUROVASCULAR NEUROLOGY DEVICES MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. NEUROVASCULAR NEUROLOGY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 5. NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY CAROTID ARTERY STENTING SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL ANEURYSM & AVM ENDOVASCULAR EMBOLIZATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL THROMBECTOMY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERTER FOR ANEURYSM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY INTRACRANIAL STENT SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL ANEURYSM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL ARTERY STENOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY STROKE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. NEUROVASCULAR NEUROLOGY DEVICES MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 101. NEUROVASCULAR NEUROLOGY DEVICES MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 102. NEUROVASCULAR NEUROLOGY DEVICES MARKET LICENSE & PRICING